LOADING
Comparing Merck & Company (MRK) and Boeing Company (BA) across the Health Care and Industrials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | BA |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $307.2B | $170.7B |
| P/E Ratio | 36.7 | 77.5 |
| Forward P/E | 48.3 | 833.3 |
| PEG Ratio | 12.06 | 25.04 |
| EPS | $3.55 | $2.79 |
| Revenue Growth (YoY) | 4.9% | 8.0% |
| Profit Margin | 13.6% | 2.6% |
| Return on Equity | 18.9% | 173.5% |
| Dividend Yield | 2.53% | -- |
| Beta | 0.20 | 1.21 |
| 52-Week High | $135.05 | $254.35 |
| 52-Week Low | $75.81 | $176.77 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.